Bone marrow-derived CD133+ stem cells for treatment of ischemic heart disease
Bone marrow-derived CD133+ stem cells can be used for treatment of ischemic heart disease. This trial aims to compare the effect of intra-coronary versus intramyocardial administration of autologous bone marrow-derived CD133+ stem cells for patients with ischemic heart disease.
Read More
Product Information for
Bone marrow-derived CD133+ stem cells for treatment of ischemic heart disease
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access